Teladoc Health Stock Forecast, Price & News

$151.56
-4.47 (-2.86 %)
(As of 07/30/2021 11:51 AM ET)
Add
Compare
Today's Range
$150.80
$155.16
50-Day Range
$140.52
$171.36
52-Week Range
$129.74
$308.00
Volume63,185 shs
Average Volume3.29 million shs
Market Capitalization$23.42 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.27
30 days | 90 days | 365 days | Advanced Chart
Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.


Teladoc Health logo

About Teladoc Health

Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers its products and services under the Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.01 out of 5 stars

Medical Sector

255th out of 2,216 stocks

Offices & Clinics Of Medical Doctors Industry

3rd out of 13 stocks

Analyst Opinion: 4.3Community Rank: 3.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Teladoc Health (NYSE:TDOC) Frequently Asked Questions

Is Teladoc Health a buy right now?

27 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 12 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Teladoc Health stock.
View analyst ratings for Teladoc Health
or view top-rated stocks.

What stocks does MarketBeat like better than Teladoc Health?

Wall Street analysts have given Teladoc Health a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Teladoc Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for Teladoc Health
.

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) released its quarterly earnings data on Tuesday, July, 27th. The health services provider reported ($0.86) earnings per share for the quarter, missing the consensus estimate of ($0.59) by $0.27. The health services provider earned $503.14 million during the quarter, compared to analysts' expectations of $499.85 million. Teladoc Health had a negative trailing twelve-month return on equity of 0.60% and a negative net margin of 47.93%. The company's quarterly revenue was up 108.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.34) EPS.
View Teladoc Health's earnings history
.

How has Teladoc Health's stock been impacted by Coronavirus (COVID-19)?

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TDOC shares have increased by 10.7% and is now trading at $152.05.
View which stocks have been most impacted by COVID-19
.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health updated its FY 2021 earnings guidance on Tuesday, July, 27th. The company provided earnings per share (EPS) guidance of $-3.600-$-3.350 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-2.750. The company issued revenue guidance of $2 billion-$2.03 billion, compared to the consensus revenue estimate of $2.01 billion.

What price target have analysts set for TDOC?

27 equities research analysts have issued twelve-month price targets for Teladoc Health's stock. Their forecasts range from $153.00 to $295.00. On average, they anticipate Teladoc Health's stock price to reach $226.56 in the next year. This suggests a possible upside of 49.0% from the stock's current price.
View analysts' price targets for Teladoc Health
or view top-rated stocks among Wall Street analysts.

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the following people:
  • Mr. Jason Nathanial Gorevic, CEO & Director (Age 49, Pay $1.66M)
  • Ms. Mala Murthy, Chief Financial Officer (Age 57, Pay $1.09M)
  • Mr. David William Sides, Chief Operating Officer (Age 50, Pay $1.16M)
  • Mr. Adam Christian Vandervoort, Chief Legal Officer & Sec. (Age 46, Pay $736.28k)
  • Ms. Stephany Verstraete, Chief Marketing Officer & Engagement Officer (Age 52, Pay $664.38k)
  • Dr. George Byron Brooks, Co-Founder
  • Mr. Richard J. Napolitano, Sr. VP, Chief Accounting Officer & Controller (Age 54)
  • Mr. Jeffrey Nadler, Chief Information Officer (Age 57)
  • Mr. Patrick Thomas Feeley C.F.A., CPA, CPA, CFA, VP of Investor Relations
  • Ms. Courtney Kraemer McLeod, Director of Communication

What is Jason Gorevic's approval rating as Teladoc Health's CEO?

106 employees have rated Teladoc Health CEO Jason Gorevic on Glassdoor.com. Jason Gorevic has an approval rating of 95% among Teladoc Health's employees. This puts Jason Gorevic in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Teladoc Health's key competitors?

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Square (SQ), Shopify (SHOP), DocuSign (DOCU), salesforce.com (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

When did Teladoc Health IPO?

(TDOC) raised $112 million in an IPO on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by many different retail and institutional investors. Top institutional shareholders include Spence Asset Management (0.06%), Vancity Investment Management Ltd (0.04%), LaFleur & Godfrey LLC (0.04%), Teamwork Financial Advisors LLC (0.01%), IFM Investors Pty Ltd (0.01%) and Lake Street Financial LLC (0.01%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David L Shedlarz, David Travers, David William Sides, Gabriel R Cappucci, Glen Tullman, Hemant Taneja, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Sandra L Fenwick, Stephany Verstraete, William H Frist and Yulun Wang.
View institutional ownership trends for Teladoc Health
.

Which institutional investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Compagnie Lombard Odier SCmA, Gradient Investments LLC, Westwood Management Corp IL, Teamwork Financial Advisors LLC, Harel Insurance Investments & Financial Services Ltd., Stratos Wealth Partners LTD., Meridian Wealth Management LLC, and Cottage Street Advisors LLC. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David Travers, David William Sides, Glen Tullman, Hemant Taneja, Jason N Gorevic, Lewis Levy, Mala Murthy, Sandra L Fenwick, Stephany Verstraete, William H Frist, and Yulun Wang.
View insider buying and selling activity for Teladoc Health
or view top insider-selling stocks.

Which institutional investors are buying Teladoc Health stock?

TDOC stock was bought by a variety of institutional investors in the last quarter, including XR Securities LLC, IFM Investors Pty Ltd, LaFleur & Godfrey LLC, Vancity Investment Management Ltd, Traynor Capital Management Inc., DAVENPORT & Co LLC, Riversedge Advisors LLC, and Avondale Wealth Management.
View insider buying and selling activity for Teladoc Health
or or view top insider-buying stocks.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $152.05.

How much money does Teladoc Health make?

Teladoc Health has a market capitalization of $23.50 billion and generates $1.09 billion in revenue each year. The health services provider earns $-485,140,000.00 in net income (profit) each year or ($1.13) on an earnings per share basis.

How many employees does Teladoc Health have?

Teladoc Health employs 4,400 workers across the globe.

Does Teladoc Health have any subsidiaries?

The following companies are subsidiares of Teladoc Health: AM Healthcare Management Consulting Sdn. Bhd., AMHMS - Health Care Management Services S.A., Advance Holdco Limited, Advance Medical, Advance Medical - Serviços de Consultoria e Gestão de Dados Ltda, Advance Medical Health Care Management Services Chile S.A., Advance Medical Hungary Tanácsadó és Szolgáltató Korlátolt Felelösségü Társaság, Advance Medical Inc., AmeriDoc, Best Doctors, Best Doctors Australasia Pty Limited, Best Doctors Holdings Inc., Best Doctors Inc., Best Doctors International Insurance S.a.r.l., Best Doctors Portugal Ltd., BetterHelp, CogCubed, Compile Inc., Consult A Doctor, HY Holdings Inc., Healthiest You, Institute of Patient Safety and Quality in Virtual Care LLC, Intouch Health, Livongo, MedecinDirect, Médecin Direct, Rise Health Inc., Stat Doctors, Stat Health LLC, TELADOC HEALTH INTERNATIONAL SOCIEDAD ANÓNIMA, TelaDietitian, Teladoc Health Canada Inc., Teladoc Health Massachusetts Holdings Inc., Teladoc Health UK Ltd., and Yi Yi Medical Health Management Consulting (Shanghai) Co. Ltd..

When was Teladoc Health founded?

Teladoc Health was founded in 2002.

What is Teladoc Health's official website?

The official website for Teladoc Health is www.teladochealth.com.

Where are Teladoc Health's headquarters?

Teladoc Health is headquartered at 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at (203) 635-2002 or via email at [email protected]


This page was last updated on 7/30/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.